BHAVNISH PARIKH,DILIP P. MODI,KRISHNASWAMY YELESWARAM,TRUPTI SHETH
申请号：
BR112016002571
公开号：
BR112016002571A2
申请日:
2014.08.06
申请国别(地区):
BR
年份:
2017
代理人:
摘要：
This invention relates to sustained release dosage forms comprising {1- {1- [3-fluor-2- (trifluoromethyl) isonicotinoyl] piperidin-4-yl} -3- [4- (7h-pyrrolo [2, 3-d] pyrimidin-4-yl) -1h-pyrazol-1-yl] azetidin-3-yl} acetonitrile, or a pharmaceutically acceptable salt and related doses and methods.esta invenção refere-se às formas de dosagem de liberação sustentada compreendendo {1-{1-[3-fluor-2-(trifluormetil)isonicotinoil]piperidin-4-il}-3-[4-(7h-pirrolo[2,3-d]pirimidin-4-il)-1h-pirazol-1-il]azetidin-3-il}acetonitrila, ou um sal farmaceuticamente aceitável e doses e métodos relacionados aos mesmos.
